These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

64 related items for PubMed ID: 7969053

  • 41. Comparison of fast responses to serotonin and 2-methyl-serotonin in voltage-clamped N1E-115 neuroblastoma cells.
    Mienville JM.
    Neurosci Lett; 1991 Nov 25; 133(1):41-4. PubMed ID: 1791997
    [Abstract] [Full Text] [Related]

  • 42. Conformationally-restricted analogues and partition coefficients of the 5-HT3 serotonin receptor ligands meta-chlorophenylbiguanide (mCPBG) and meta-chlorophenylguanidine (mCPG).
    Rahman AA, Daoud MK, Dukat M, Herrick-Davis K, Purohit A, Teitler M, do Amaral AT, Malvezzi A, Glennon RA.
    Bioorg Med Chem Lett; 2003 Mar 24; 13(6):1119-23. PubMed ID: 12643925
    [Abstract] [Full Text] [Related]

  • 43. Interaction of a biguanide compound with membrane model interface systems: probing the properties of antimalaria and antidiabetic compounds.
    Samart N, Beuning CN, Haller KJ, Rithner CD, Crans DC.
    Langmuir; 2014 Jul 29; 30(29):8697-706. PubMed ID: 24956022
    [Abstract] [Full Text] [Related]

  • 44. Time-dependent changes in spontaneous respiratory activity in turtle brainstems in vitro.
    Wilkerson JE, Wenninger MR, Mitchell GS, Johnson SM.
    Respir Physiol Neurobiol; 2003 Nov 14; 138(2-3):253-63. PubMed ID: 14609514
    [Abstract] [Full Text] [Related]

  • 45. 3-(2-Carboxyethyl)indole-2-carboxylic Acid Derivatives: Structural Requirements and Properties of Potent Agonists of the Orphan G Protein-Coupled Receptor GPR17.
    Baqi Y, Pillaiyar T, Abdelrahman A, Kaufmann O, Alshaibani S, Rafehi M, Ghasimi S, Akkari R, Ritter K, Simon K, Spinrath A, Kostenis E, Zhao Q, Köse M, Namasivayam V, Müller CE.
    J Med Chem; 2018 Sep 27; 61(18):8136-8154. PubMed ID: 30048589
    [Abstract] [Full Text] [Related]

  • 46. Relationship between tissue culture cytotoxicity and acute toxicity in mice of biguanide derivatives.
    Rikimaru M, Nishikawa T, Shimizu Y, Ishida N, Katsube J, Kadota T, Saijo S.
    J Antibiot (Tokyo); 1965 Jul 27; 18(4):196-9. PubMed ID: 5898338
    [No Abstract] [Full Text] [Related]

  • 47. X-Ray Crystal Structure of a 2-Amino-3,4-dihydroquinazoline 5-HT3 Serotonin Receptor Antagonist and Related Analogs.
    Abdelkhalek AS, Musayev FN, Iyer KA, Hemanth P, Safo MK, Dukat M.
    J Mol Struct; 2020 Feb 15; 1202():. PubMed ID: 32616964
    [Abstract] [Full Text] [Related]

  • 48. [Structure of acyl and biguanide derivatives of mu-aminobenzoic acid].
    Solonskaia NT, Blizniukov VI.
    Farm Zh; 1969 Feb 15; 24(5):19-23. PubMed ID: 5362990
    [No Abstract] [Full Text] [Related]

  • 49. [Structure of acyl and biguanide derivatives of para-aminobenzoic acid].
    Solon'skaia NT, Blizniukov VI.
    Farm Zh; 1969 Feb 15; 24(1):15-8. PubMed ID: 5782278
    [No Abstract] [Full Text] [Related]

  • 50. 2-Phenyl-biguanidinium hydrogen succinate methanol monosolvate.
    Matulková I, Císařová I, Němec I.
    Acta Crystallogr Sect E Struct Rep Online; 2010 Nov 17; 66(Pt 12):o3187-8. PubMed ID: 21589482
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Biguanide derivatives: agonist pharmacology at 5-hydroxytryptamine type 3 receptors in vitro.
    Morain P, Abraham C, Portevin B, De Nanteuil G.
    Mol Pharmacol; 1994 Oct 17; 46(4):732-42. PubMed ID: 7969053
    [Abstract] [Full Text] [Related]

  • 54. Identification of serotonin 5-HT3 recognition sites in membranes of N1E-115 neuroblastoma cells by radioligand binding.
    Hoyer D, Neijt HC.
    Mol Pharmacol; 1988 Mar 17; 33(3):303-9. PubMed ID: 3352595
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 1. Mapping the central 5-HT3 receptor binding site by arylpiperazine derivatives.
    Cappelli A, Anzini M, Vomero S, Mennuni L, Makovec F, Doucet E, Hamon M, Bruni G, Romeo MR, Menziani MC, De Benedetti PG, Langer T.
    J Med Chem; 1998 Feb 26; 41(5):728-41. PubMed ID: 9513601
    [Abstract] [Full Text] [Related]

  • 57. Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamine and [3H]alniditan.
    Leysen JE, Gommeren W, Heylen L, Luyten WH, Van de Weyer I, Vanhoenacker P, Haegeman G, Schotte A, Van Gompel P, Wouters R, Lesage AS.
    Mol Pharmacol; 1996 Dec 26; 50(6):1567-80. PubMed ID: 8967979
    [Abstract] [Full Text] [Related]

  • 58. Biguanide derivatives: agonist pharmacology at 5-hydroxytryptamine type 3 receptors in vitro.
    Morain P, Abraham C, Portevin B, De Nanteuil G.
    Mol Pharmacol; 1994 Oct 26; 46(4):732-42. PubMed ID: 7969053
    [Abstract] [Full Text] [Related]

  • 59. Identification of serotonin 5-HT3 recognition sites in membranes of N1E-115 neuroblastoma cells by radioligand binding.
    Hoyer D, Neijt HC.
    Mol Pharmacol; 1988 Mar 26; 33(3):303-9. PubMed ID: 3352595
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.